Raphael J. Landovitz, MD, MSc, is an infectious disease physician-scientist at UCLA. He serves as Chief of the Division of Infectious Diseases and Associate Vice Chair for Clinical Research in the UCLA Department of Medicine, and he holds the Mary D. Fisher Endowed Chair in HIV Care, Treatment, and Prevention. His clinical practice centers on complex infectious diseases care, prevention medicine, and sexual health. Dr. Landovitz’s research focuses on antiviral therapeutics, biomedical prevention strategies, and global clinical trials and implementation science. He also serves as Director of the UCLA Clinical AIDS Research and Education Center, Director of the Center for HIV Identification, Prevention, and Treatment Services, and a Multiple Principal Investigator for the UCLA AIDS Prevention and Treatment Clinical Trials Unit. His national and international leadership includes service on the Scientific Leadership Board of IAS-USA, consulting work with the World Health Organization, and editorial board service for AIDS. His honors include the John Carey Young Investigator Award, the HIVMA Research Award, the Ward Cates Award, and the Donna Davis Community Award. He is MPI of the NIH Division of AIDS funded HIV Prevention Trials Network (HPTN). He earned his MD from Harvard Medical School and completed his residency in internal medicine at Brigham and Women’s Hospital, where he also served as Chief Resident. He went on to complete fellowship training in infectious diseases at Brigham and Women’s Hospital and Massachusetts General Hospital, and later earned an MSc in Clinical Research from UCLA.
Division Chief
2023 – present
Medical School
1992 – 1996
Residency
1996 – 1999
Fellowship
1999 – 2001